Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
Agios Pharmaceuticals, Inc. will present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024. The presentation will focus on the company's pioneering therapies for rare diseases in the field of cellular metabolism.
02/22/2024 - 07:00 AM
CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced that the company is scheduled to present at the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024, at 2:10 p.m. ET.
A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com . A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation.
About Agios www.agios.com .
Contacts:
Investor Contact IR@agios.com
Media Contact dan@1abmedia.com
When is Agios Pharmaceuticals, Inc. presenting at the TD Cowen 44th Annual Health Care Conference?
Agios Pharmaceuticals, Inc. is scheduled to present at the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024, at 2:10 p.m. ET.
What is the focus of Agios Pharmaceuticals, Inc.'s presentation at the conference?
The presentation will focus on Agios Pharmaceuticals, Inc.'s pioneering therapies for rare diseases in the field of cellular metabolism.
Where can the live webcast of Agios Pharmaceuticals, Inc.'s presentation be accessed?
The live webcast of the presentation can be accessed under 'Events & Presentations' in the Investors section of the company's website at www.agios.com.
How long will the webcast replay be available on Agios Pharmaceuticals, Inc.'s website?
A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation.
Agios Pharmaceuticals Inc
AGIO Rankings
#3738 Ranked by Stock Gains
AGIO Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Cambridge
About AGIO
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
